Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To date there is no firm conclusion as to the efficacy and safety of ibuprofen compared
with indometacin for patent ductus arteriosus (PDA) closure in extremely premature
infants.